A study examined over 6 months the rehabilitative effects of Apos® on patients following total hip replacement surgery. It found the treatment to significantly reduce pain and improve function, quality of life and gait patterns.
A prospective pilot study examined the effect of Apos® treatment on the rehabilitation outcomes of subjects following total hip arthroplasty (THA, i.e., hip replacement).
The study evaluated 19 subjects following their hip replacement surgery, assessing them for a period of 6 months.
The study found a significant reduction in the subjects’ pain levels (85%), an increase in function (81%) and quality of life (61%) and a significant improvement in gait (walking) patterns – including gait speed, step length and single limb support.
